|
Orthologous residues
|
|
PPP1R2 (human): S44‑p, PPP1R2 (mouse): S45‑p, PPP1R2 (rat): S44‑p, PPP1R2 (rabbit): S44‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Disease tissue studied:
ataxia-telangiectasia
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), GM01526 (fibroblast), GM0536 (fibroblast), HeLa (cervical)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATM (human)
|
genetic knockout/knockin of upstream enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
ionizing radiation
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
cell cycle regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
PPP1CA (human)
|
|
Disrupts
|
enzymatic activity, induced
|
|
co-immunoprecipitation
|
|
|
Comments:
in response to IR-induced DNA damage
|